Saurabh Satija

Dr. Saurabh Satija is a Lecturer in Medical Sciences at the University of Wollongong's School of Medical, Indigenous & Health Sciences. He holds a Ph.D. from Maharshi Dayanand University (2017) and has over 11 years of academic experience across institutions in India and Australia. His research focuses on natural products drug delivery, cancer nanotechnology, and LC-MS lipidomics for inflammation biomarkers. Dr. Satija has secured grants including a Cancer Institute NSW Translational Grant (2023-2024) for CRISPR/Cas9 nanoparticle development targeting pancreatic cancer.

His research contributions include over 50 Web of Science-indexed publications and three patents (2 Australian, 1 Indian). Key projects include nanotechnology applications in drug delivery at Lovely Professional University and collaborative work at the Kolling Institute of Medical Research. Teaching roles span pharmaceutical sciences across multiple universities, emphasizing both synchronous/asynchronous learning methods.

Dr. Satija's current work integrates analytical chemistry (HPLC/HPTLC) with translational research, particularly in overcoming chemoresistance through gene-editing technologies. He has also led equipment repair initiatives at the University of Wollongong's mass spectrometry facility.